Stronach Group

Stronach Group, a leading horse racetrack operator, uses NeoPlate technology for equine drug screening. A pilot project for the 2016 season is slated to test 150 racehorses for banned or prohibited substances.

Request Information

More Case Studies
DS Laboratories
October 4, 2015